TABLE 5.
Peptide | Sp act (μmol min−1) | Relative activitya |
---|---|---|
DI | 659 | 120 |
DF | 579 | 105 |
DL | 550 | 100 |
DY | 476 | 86 |
DC | 348 | 63 |
DH | 301 | 55 |
DQ | 257 | 47 |
DE | 200 | 36 |
DW | 164 | 30 |
DA | 177 | 32 |
DS | 126 | 23 |
DV | 119 | 22 |
DN | 71 | 13 |
DM | 69 | 12 |
DG | 59 | 11 |
DT | 25 | 4 |
DD | 21 | 4 |
DR | 2 | 0.4 |
DP | 0.7 | 0.1 |
DK | <0.5 | <0.09 |
EW | 124 | 22 |
EY | 114 | 21 |
EV | 43 | 8 |
EA | 41 | 7 |
EG | 26 | 5 |
EK | 16 | 3 |
Relative activity with respect to Asp-Leu activity (550 μmol min−1 mg−1).